Providence Hematology Logo



linical research is a way of providing new and innovative care to patients who can potentially benefit from new directions in medicine. Our hematologists are actively engaged in clinical research and investigate both benign and malignant hematological disorders. The aim of this research is to identify significant improvements in treatment and patient care; it is this inspiration that is the spirit and vision of our research team.You may be interested in participating in a clinical study. If so, please contact your doctor, and we will see if there is a study that is right for you.

The team is committed to Good Clinical Practice (GCP), and our staff brings a wide range of experience, both local and international, to the group. The Hematology and Oncology Research Program at St. Paul’s Hospital is directed by Dr. Heather Leitch, and was pioneered and founded by Dr. Linda Vickars. The team is comprised of our hematologists, who all act as investigators, along with four other clinical research professionals. Our hematologists include Dr. Shannon Jackson, Dr. Chantal Léger, Dr. Heather Leitch, Dr. Khaled Ramadan, Dr. Hatoon Ezzat, Dr. Camilla Ross and  Dr. Lynda Foltz as the Division Head. Our clinical research professional team also includes Evvie Fikeris, Michelle Mony, Carolina Novoa and Rachel Despotovic.

  • Areas of active research include the investigation of new treatments for patients with acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, non-Hodgkin lymphoma, HIV-related lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative disorders, idiopathic thrombocytopenic purpura, hemophilia & bleeding disorders, hemoglobinopathies, thrombosis and other blood-related conditions. Future studies may address additional blood problems.

  • You can support the growth of great research in blood disorders and blood cancers!   [Click here]

    This is an exciting time for research. Our research has grown steadily over the last decade in terms of both numbers and complexity. Patients with four diseases account for most of this increase: non-Hodgkin lymphoma, acute leukemia (largely acute myeloid leukemia), multiple myeloma and chronic lymphocytic leukemia. These disease areas all increase in frequency, largely as a result of the general aging of the population. We will continue to deliver the best care to our patients and we are excited to play an active role in research development.

  • Our investigators also offer customizable educational opportunities to community members. If this interests you, please contact us today and learn with our investigators!   [Click here]

  • Our team is also proud to involve students and trainees in our research program. Projects investigating areas in hematology/oncology offer an exciting opportunity to do real research. Individuals who are interested in partaking in a summer research project within the Hematology/Oncology Research Program should contact one of our members.

View our list of publications here:


Meet the Research Staff

From left to right: Michelle Mony (Research Coordinator), Carolina Novoa (Research Manager) and Evvie Fikeris (Research Coordinator).